TP53 and esophageal squamous cell carcinoma: Our observation confirmed that immunohistochemical detection of p53 protein expression could more effectively reflect the relationship with prognosis and clinicopathologic features than the mutation status of the TP53 gene in ESCC, which was further supported by studies with a larger sample.